Glycogen synthase kinase-3 (GSK-3) inhibitors reach the clinic - PubMed (original) (raw)

Affiliations

• PMID: 18600569

Review

Glycogen synthase kinase-3 (GSK-3) inhibitors reach the clinic

Miguel Medina et al. Curr Opin Drug Discov Devel. 2008 Jul.

Abstract

It is just over a quarter of a century since the original identification and characterization of glycogen synthase kinase-3 (GSK-3), a major protein kinase that is involved in the regulation of glucose metabolism. GSK-3 modulates the function of a diverse series of proteins, as well as being associated with a wide variety of human disorders, including neurodegenerative diseases, stroke, bipolar disorder, diabetes and cancer. Not surprisingly, GSK-3 has attracted significant attention as a therapeutic target and as a means to understand the molecular basis of these disorders. Small-molecule GSK-3 inhibitors have now started to reach clinical development for the treatment of various disorders.

PubMed Disclaimer

Similar articles

• Preclinical efficacy on GSK-3 inhibitors: towards a future generation of powerful drugs.
  Martinez A. Martinez A. Med Res Rev. 2008 Sep;28(5):773-96. doi: 10.1002/med.20119. Med Res Rev. 2008. PMID: 18271054 Review.
• Glycogen synthase kinase 3 (GSK-3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation.
  Martinez A, Castro A, Dorronsoro I, Alonso M. Martinez A, et al. Med Res Rev. 2002 Jul;22(4):373-84. doi: 10.1002/med.10011. Med Res Rev. 2002. PMID: 12111750 Review.
• [A new target for diabetes therapy: advances in the research of glycogen synthase kinase-3 inhibitors].
  Liu SN, Shen ZF. Liu SN, et al. Yao Xue Xue Bao. 2007 Dec;42(12):1227-31. Yao Xue Xue Bao. 2007. PMID: 18338632 Review. Chinese.
• QSAR modeling of the inhibition of glycogen synthase kinase-3.
  Katritzky AR, Pacureanu LM, Dobchev DA, Fara DC, Duchowicz PR, Karelson M. Katritzky AR, et al. Bioorg Med Chem. 2006 Jul 15;14(14):4987-5002. doi: 10.1016/j.bmc.2006.03.009. Epub 2006 May 2. Bioorg Med Chem. 2006. PMID: 16650999
• Design and synthesis of 7-hydroxy-1H-benzoimidazole derivatives as novel inhibitors of glycogen synthase kinase-3beta.
  Shin D, Lee SC, Heo YS, Lee WY, Cho YS, Kim YE, Hyun YL, Cho JM, Lee YS, Ro S. Shin D, et al. Bioorg Med Chem Lett. 2007 Oct 15;17(20):5686-9. doi: 10.1016/j.bmcl.2007.07.056. Epub 2007 Aug 19. Bioorg Med Chem Lett. 2007. PMID: 17764934

Cited by

• New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.
  Maes M, Fišar Z, Medina M, Scapagnini G, Nowak G, Berk M. Maes M, et al. Inflammopharmacology. 2012 Jun;20(3):127-50. doi: 10.1007/s10787-011-0111-7. Epub 2012 Jan 24. Inflammopharmacology. 2012. PMID: 22271002 Review.
• Molecular Pathways: Revisiting Glycogen Synthase Kinase-3β as a Target for the Treatment of Cancer.
  Walz A, Ugolkov A, Chandra S, Kozikowski A, Carneiro BA, O'Halloran TV, Giles FJ, Billadeau DD, Mazar AP. Walz A, et al. Clin Cancer Res. 2017 Apr 15;23(8):1891-1897. doi: 10.1158/1078-0432.CCR-15-2240. Epub 2017 Jan 4. Clin Cancer Res. 2017. PMID: 28053024 Free PMC article. Review.
• Stable mutated tau441 transfected SH-SY5Y cells as screening tool for Alzheimer's disease drug candidates.
  Löffler T, Flunkert S, Taub N, Schofield EL, Ward MA, Windisch M, Hutter-Paier B. Löffler T, et al. J Mol Neurosci. 2012 May;47(1):192-203. doi: 10.1007/s12031-012-9716-6. Epub 2012 Feb 19. J Mol Neurosci. 2012. PMID: 22351109 Free PMC article.
• Aspects of astrocyte energy metabolism, amino acid neurotransmitter homoeostasis and metabolic compartmentation.
  Kreft M, Bak LK, Waagepetersen HS, Schousboe A. Kreft M, et al. ASN Neuro. 2012 Apr 27;4(3):e00086. doi: 10.1042/AN20120007. ASN Neuro. 2012. PMID: 22435484 Free PMC article. Review.
• Oral administration of a GSK3 inhibitor increases brain insulin-like growth factor I levels.
  Bolós M, Fernandez S, Torres-Aleman I. Bolós M, et al. J Biol Chem. 2010 Jun 4;285(23):17693-700. doi: 10.1074/jbc.M109.096594. Epub 2010 Mar 29. J Biol Chem. 2010. PMID: 20351102 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Other Literature Sources

  • The Lens - Patent Citations Database